Overview

Gender

male

Troy Wilson is a highly-successful, serial entrepreneur. His passion is to build exceptional companies that create significant value for employees, investors and most importantly, patients. In addition to his role as President and CEO of Avidity NanoMedicines, Troy Wilson is President and CEO of Wellspring Biosciences as well as its affiliated company, Araxes Pharma. He also serves as a director of Puma Biotechnology, a biopharmaceutical company dedicated to the acquisition and development of novel therapeutics for the treatment of cancer.

Troy Wilson previously served as President and CEO of Intellikine, a company which he co-founded and which was acquired by Takeda Pharmaceuticals in January 2012 for up to $310 million, and prior to Intellikine he was involved with the formation, launch and growth of several other companies. Troy Wilson received his Ph.D. degree in bioorganic chemistry from the University of California, Berkeley and his law degree from New York University.